BridgeMD
New treatment option for First Episode Psychosis
Official title Artificial Intelligence to Measure Adherence to Oral Medication
ClinicalTrials.gov ID: NCT04046497
What this study is testing
- What it's testing
- The aims of this project is to use an artificial intelligence (AI) smartphone app to provide support for medication adherence by patients with first episode psychosis.
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 15 to 40
You may be able to join if
- Enrolled in a CSC program
- Prescribed an oral antipsychotic
You likely can't join if
- none
The study team makes the final eligibility decision.
Where it's taking place
- Hialeah, Florida, United States
- Grand Rapids, Michigan, United States
- Kalamazoo, Michigan, United States
- Oklahoma City, Oklahoma, United States
- Tulsa, Oklahoma, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 15 years to 40 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hialeah, Florida, United States; Grand Rapids, Michigan, United States; Kalamazoo, Michigan, United States; Oklahoma City, Oklahoma, United States; Tulsa, Oklahoma, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.